Expanding access to treatment and steady demand in the fertility treatment market
First written in FY2026-H1. 5 of 7 entries say "Restated". Latest entry: 2026-07-31.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「In the infertility treatment sector in which our Group operates, demand has remained firm both in Japan and overseas against a backdrop of later marriage and later childbirth. Overseas in particular, the market is expected to grow over the medium to long term as medical standards improve and access to treatment expands.」
Reaffirms the outlook for medium- to long-term market growth, supported by firm demand for fertility treatment and expanded access to treatment overseas. - FY2026-H1First statedAnnual report
「In the fertility treatment field, interest in advanced treatment technologies remains high in Japan against a backdrop of declining births and later marriage, while demand overseas remains firm, supported by expanded access to treatment and improvements in healthcare standards.」
Describes the structural background and current conditions affecting domestic and overseas demand in the fertility treatment field.